The authors, therefore, suggest that the exosomal content of β4 and VCL could represent a predictive marker for taxane resistance in prostate carcinoma patients; interestingly, these data also highlight the possibility that the horizontal transfer of β4 and VCL to other cancer cells could confer or enhance migratory skills of the target cells. The gene discussed is VCL; the disease is prostate carcinoma.